Cargando…

Pulmonary Embolism and Heart Failure: A Reappraisal

Acute heart failure and acute pulmonary embolism share many features, including epidemiological aspects, clinical presentation, risk factors and pathobiological mechanisms. As such, it is not surprising that diagnosis and management of these common conditions might be challenging for the treating ph...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arrigo, Mattia, Huber, Lars Christian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Radcliffe Cardiology 2021
Materias:	Treatment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7926477/ https://www.ncbi.nlm.nih.gov/pubmed/33708418 http://dx.doi.org/10.15420/cfr.2020.26

Ejemplares similares

The Future of Telemedicine in the Management of Heart Failure Patients
por: Silva-Cardoso, José, et al.
Publicado: (2021)

Clinical importance of urinary sodium excretion in acute heart failure
por: Damman, Kevin, et al.
Publicado: (2020)

Which patients with heart failure should receive specialist palliative care?
por: Campbell, Ross T., et al.
Publicado: (2018)

Unequitable Heart Failure Therapy for Black, Hispanic and American-Indian Patients
por: Ilonze, Onyedika, et al.
Publicado: (2022)

Why Do so Few People with Heart Failure Receive Cardiac Rehabilitation?
por: Thompson, David R, et al.
Publicado: (2022)

Remote Patient Monitoring for Patients with Heart Failure: Sex- and Race-based Disparities and Opportunities
por: Mastoris, Ioannis, et al.
Publicado: (2023)

Pathophysiological Rationale and Clinical Evidence for Neurohormonal Modulation in Heart Failure with Preserved Ejection Fraction
por: Castiglione, Vincenzo, et al.
Publicado: (2023)

Sodium–Glucose Co-transporter 2 Inhibitors in Heart Failure: Recent Data and Implications for Practice
por: Rosano, Giuseppe, et al.
Publicado: (2020)

Titration to target dose of bisoprolol vs. carvedilol in elderly patients with heart failure: the CIBIS-ELD trial
por: Düngen, Hans-Dirk, et al.
Publicado: (2011)

In-hospital Initiation and Up-titration of Guideline-directed Medical Therapies for Heart Failure with Reduced Ejection Fraction
por: Cox, Zachary L, et al.
Publicado: (2022)

Efficacy and safety of nebivolol in elderly heart failure patients with impaired renal function: insights from the SENIORS trial
por: Cohen-Solal, Alain, et al.
Publicado: (2009)

Effect of patiromer on reducing serum potassium and preventing recurrent hyperkalaemia in patients with heart failure and chronic kidney disease on RAAS inhibitors
por: Pitt, Bertram, et al.
Publicado: (2015)

The Gap to Fill: Rationale for Rapid Initiation and Optimal Titration of Comprehensive Disease-modifying Medical Therapy for Heart Failure with Reduced Ejection Fraction
por: Brownell, Nicholas K, et al.
Publicado: (2021)

A randomized, double-blind, placebo-controlled study to determine the effects of valsartan on exercise time in patients with symptomatic heart failure with preserved ejection fraction
por: Parthasarathy, Hari K., et al.
Publicado: (2009)

Baseline characteristics and treatment of patients in Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM-HF)
por: McMurray, John J V, et al.
Publicado: (2014)

Patiromer versus placebo to enable spironolactone use in patients with resistant hypertension and chronic kidney disease (AMBER): results in the pre‐specified subgroup with heart failure
por: Rossignol, Patrick, et al.
Publicado: (2020)

Treatment of Persistent Left Atrial Appendage Thrombus in Patients with Atrial Fibrillation on Adequate Oral Anticoagulation: Pathways of Care for All-comers and Heart Failure Patients
por: Katic, Josip, et al.
Publicado: (2023)

Maintenance of serum potassium with sodium zirconium cyclosilicate (ZS‐9) in heart failure patients: results from a phase 3 randomized, double‐blind, placebo‐controlled trial
por: Anker, Stefan D., et al.
Publicado: (2015)

Management protocols for chronic heart failure in India
por: Mishra, S., et al.
Publicado: (2018)

Mechanical Circulatory Support for Right Ventricular Failure
por: DeFilippis, Ersilia M, et al.
Publicado: (2022)

Pirfenidone for Idiopathic Pulmonary Fibrosis and Beyond
por: Aimo, Alberto, et al.
Publicado: (2022)

Ruling out Pulmonary Embolism in Patients with High Pretest Probability
por: Akhter, Murtaza, et al.
Publicado: (2018)

The effects of short‐term omission of daily medication on the pathophysiology of heart failure
por: Dovancescu, Silviu, et al.
Publicado: (2017)

Emergency Department Patient Satisfaction with Treatment of Low-risk Pulmonary Embolism
por: Simon, Laura E., et al.
Publicado: (2018)

Assessing costs of a hypertension management program: An application of the HEARTS costing tool in a program planning workshop in Thailand
por: Husain, Muhammad Jami, et al.
Publicado: (2019)

Nine-year follow-up of local implantation of autologous skeletal myoblasts in a patient with coronary heart disease
por: Zhang, Dingguo, et al.
Publicado: (2013)

Age differences in contemporary treatment of patients with chronic heart failure and reduced ejection fraction
por: Veenis, Jesse F, et al.
Publicado: (2019)

Reappraisal on pharmacological and mechanical treatments of heart failure
por: Liang, Bo, et al.
Publicado: (2020)

Initiating sacubitril/valsartan (LCZ696) in heart failure: results of TITRATION, a double‐blind, randomized comparison of two uptitration regimens
por: Senni, Michele, et al.
Publicado: (2016)

Efficacy of As-Needed Nalmefene in Alcohol-Dependent Patients with at Least a High Drinking Risk Level: Results from a Subgroup Analysis of Two Randomized Controlled 6-Month Studies
por: van den Brink, Wim, et al.
Publicado: (2013)

Use of evidence‐based therapy in heart failure with reduced ejection fraction across age strata
por: Stolfo, Davide, et al.
Publicado: (2022)

Dronedarone for the treatment of atrial fibrillation with concomitant heart failure with preserved and mildly reduced ejection fraction: a post‐hoc analysis of the ATHENA trial
por: Vaduganathan, Muthiah, et al.
Publicado: (2022)

Efficacy of sacubitril/valsartan vs. enalapril at lower than target doses in heart failure with reduced ejection fraction: the PARADIGM‐HF trial
por: Vardeny, Orly, et al.
Publicado: (2016)

A Phase 2a dose‐escalation study of the safety, tolerability, pharmacokinetics and haemodynamic effects of BMS‐986231 in hospitalized patients with heart failure with reduced ejection fraction
por: Tita, Cristina, et al.
Publicado: (2017)

Intermediate-high and high risk acute pulmonary embolism during home confinement due to coronavirus-19 pandemic: description in a second level hospital
por: Sanz Ortega, I, et al.
Publicado: (2021)

Echocardiography accurately predicts pulmonary hypertension in patients with advanced lung disease
por: Cottini, Silvia, et al.
Publicado: (2017)

Efficacy and safety of emapalumab in macrophage activation syndrome
por: De Benedetti, Fabrizio, et al.
Publicado: (2023)

A double‐blind, placebo‐controlled trial on the antihypertensive treatment effect of a quadruple single‐pill combination
por: Hu, Lei‐Xiao, et al.
Publicado: (2021)

Twelve-Month Follow-up Results from a Randomized Controlled Trial of a Brief Personalized Feedback Intervention for Problem Drinkers
por: Cunningham, John A., et al.
Publicado: (2010)

Is methotrexate safe for men with an immune-mediated inflammatory disease and an active desire to become a father? Results of a prospective cohort study (iFAME-MTX)
por: Perez-Garcia, Luis Fernando, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ruodk4ti4cqv87749r6s4ktlf6